Cargando…
SARS-CoV-2 immunoglobulin G antibody levels in infants following messenger RNA COVID-19 vaccination during pregnancy
Autores principales: | Kugelman, Nir, Nahshon, Chen, Shaked-Mishan, Pninit, Lavie, Ofer, Stein, Nili, Kedar, Reuven, Waisman, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293368/ https://www.ncbi.nlm.nih.gov/pubmed/35863460 http://dx.doi.org/10.1016/j.ajog.2022.07.016 |
Ejemplares similares
-
Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth
por: Kugelman, Nir, et al.
Publicado: (2022) -
The rapid SARS-CoV-2 antibody qualitative test is accurate for assessing immunity following vaccination during pregnancy
por: Kugelman, Nir, et al.
Publicado: (2022) -
Newborn and maternal immunity following 2nd trimester mRNA COVID-19 vaccination
por: Kugelman, Nir, et al.
Publicado: (2022) -
Author’s Reply: Hazardous Postoperative Outcomes of Unexpected COVID-19 Infected Patients: A Call for Global Consideration of Sampling All Asymptomatic Patients Before Surgical Treatment
por: Nahshon, Chen, et al.
Publicado: (2020) -
Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy
por: Nir, Omer, et al.
Publicado: (2022)